A Study of Eltrombopag in Patients With CMML and Thrombocytopenia
Clinical trial NCT02323178 · COMPLETED
Trial details
- NCT number
- NCT02323178
- Sponsor
- Groupe Francophone des Myelodysplasies
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-07
- Primary completion
- 2018-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.